Last Price
2.32
Today's Change
0.00 (0.00%)
Day's Change
0.00 - 0.00
Trading Volume
0
Profile
ZURA
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Robert Lisicki Mr. Robert Lisicki
Full Time Employees: 14 14
IPO Date: 2023-03-21 2023-03-21
CIK: 0001855644 0001855644
ISIN: KYG9TY5A1016 KYG9TY5A1016
Beta: 0.14 0.14
Last Dividend: 0.00 0.00
Dcf Diff: -0.70 -0.70
Dcf: 3.02 3.02
Description
Zura Bio Limited, a clinical-stage biotechnology company, focuses on developing novel medicines for immune and inflammatory disorders. It develops ZB-168, an anti IL7R a inhibitor that impact on diseases driven by IL7 and TSLP biological pathways; and Torudokimab, a monoclonal antibody that neutralizes IL33, which is in Phase 2 clinical trial development. The company is based in San Diego, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
Apps
Top Articles
1
CEO Morning Brief
US New-home Sales Rebound in November After Storm-stricken Month
2
CEO Morning Brief
Orders for US Business Equipment Rise by Most in Over a Year
3
CEO Morning Brief
4
CEO Morning Brief
Google to Fight Japan’s Claims That It Hobbles Rivals in Search
5
CEO Morning Brief
Musk Makes ‘overstaffed’ US Fed Target in Quest for Efficiency
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
